| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.00074 | 1 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.00065 | 1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.0006 | 1 |